Pod těmito názvy můžete látku najít v jiných zdrojích
CELL THERAPY CONSISTING OF PRO-INFLAMMATORY MONOCYTEDERIVED DENDRITIC CELLS (MODCS), ISOLATED FROM AN ALLOGENEIC HUMAN HEALTHY BLOOD DONOR AND EX-VIVO STIMULATED WITH RESIQUIMOD (R848), POLYINOSINICPOLYCYTIDYLIC ACID (POLY(I:C)) AND INTERFERON GAMMA (IFN-GAMMA). CONTAINS AT LEAST 70% OF DENDRITIC CELLS (DC). THESE CELLS EXPRESS T-LYMPHOCYTE ACTIVATION ANTIGEN CD86 AND THE MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS II MOLECULE HLA-DR, AND SECRETE PRO-INFLAMMATORY SOLUBLE FACTORS, INCLUDING INTERLEUKIN 12 (IL-12) AND C-C MOTIF CHEMOKINE 5 (CCL5; ALSO KNOWN AS RANTES).